Search - tctmd.com

Displaying 161 - 180 of 349

Sort: Relevancy | Date

News Daily News

For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques

Todd Neale

December 20, 2015

News Daily News

En los Ensayos Intervencionistas el Tratamiento Médico Óptimo podría acarrear Formación y Técnicas Nuevas

Todd Neale

December 20, 2015

News Industry News

First Patients Enrolled in the Gore RELINE MAX Clinical Study

December 15, 2015

News Daily News

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Yael L. Maxwell

December 13, 2015

News Daily News

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Michael O'Riordan

December 07, 2015

News Daily News

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Caitlin E. Cox

November 26, 2015

News Conference News VEITH 2015

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

L.A. McKeown

November 24, 2015

News Conference News VEITH 2015

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

Yael L. Maxwell

November 19, 2015

News Conference News TCT 2015

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

Yael L. Maxwell

October 14, 2015

News Industry News

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

October 06, 2015

News Daily News

Study Supports Multiarterial CABG for Multivessel CAD

Todd Neale

September 24, 2015

News Industry News

QT Vascular wins CE Mark for drug-coated balloon

September 10, 2015

News Daily News

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

Yael L. Maxwell

August 26, 2015

News Daily News

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

Yael L. Maxwell

August 26, 2015

News Daily News

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

Yael L. Maxwell

August 26, 2015

News Daily News

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

L.A. McKeown

August 05, 2015

News Daily News

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

Yael L. Maxwell

July 31, 2015

News Industry News

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

July 29, 2015

Advertisement

For Interventional Trials, Optimal Medical Management May Entail as Much Training as New Techniques

En los Ensayos Intervencionistas el Tratamiento Médico Óptimo podría acarrear Formación y Técnicas Nuevas

First Patients Enrolled in the Gore RELINE MAX Clinical Study

Atherectomy Plus Angioplasty Reduces Mortality, Amputation Risk But Adds Hefty Initial Price

Surgery Common in Stented Patients But Newer Stents Appear to Reduce Potential Risks

Residual Dissection After DCB Treatment for De Novo CAD Generally Resolves

Controversial Intravascular Therapy for Multiple Sclerosis Moves from Cath Lab to the OR

DCBs for Femoropoliteal Disease: What’s Now and What’s Next?

LEADERS FREE: Drug-Coated Stent Bests BMS in High-Risk PCI Patients

QT Vascular Announces Interim Clinical Trial Results Of Chocolate Touch

Study Supports Multiarterial CABG for Multivessel CAD

QT Vascular wins CE Mark for drug-coated balloon

采用第二代 DES 的双支架策略在治疗分叉病变时无劣势

No Disadvantage for 2-Stent Strategy in Bifurcation Lesions With Second-Generation DES

La Estrategia de Doble Stent en Lesiones en Bifurcación con SLF de 2ª Generación No tiene Ninguna Desventaja

Dialysis a Key Predictor of Adverse Outcomes After Endovascular Intervention for CLI

In Acute MI Patients, Early QoL Advantage With DES Over BMS Disappears by 1 Year

First U.S. Patients Enroll in Boehringer Ingelheim's Global RE-DUAL PCI™ and RE-CIRCUIT™ Trials Evaluating Pradaxa® (dabigatran etexilate mesylate)

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content